Trump Media & Technology (DJTWW) had the highest return between December 27, 2023 and January 22, 2024 by a mid-cap US stock, returning 222.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Trump Media & Technology (DJTWW) | 12/27/2023 - 1/22/2024 | 222.86% |
Trump Media & Technology (DJT) | 12/27/2023 - 1/22/2024 | 172.57% |
Sezzle Inc Common Stock (SEZL) | 12/27/2023 - 1/22/2024 | 90.13% |
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS) | 12/27/2023 - 1/22/2024 | 87.72% |
Dave (DAVE) | 12/27/2023 - 1/22/2024 | 81.1% |
Sharplink Gaming (SBET) | 12/27/2023 - 1/22/2024 | 37.12% |
Alvotech (ALVO) | 12/27/2023 - 1/22/2024 | 26.38% |
Tarsus Pharmaceuticals (TARS) | 12/27/2023 - 1/22/2024 | 25.89% |
Sarepta Therapeutics (SRPT) | 12/27/2023 - 1/22/2024 | 25.17% |
ADMA Biologics (ADMA) | 12/27/2023 - 1/22/2024 | 21.33% |
Merus (MRUS) | 12/27/2023 - 1/22/2024 | 21.32% |
Ideaya Biosciences (IDYA) | 12/27/2023 - 1/22/2024 | 20.48% |
Soleno Therapeutics (SLNO) | 12/27/2023 - 1/22/2024 | 19.82% |
Oscar Health (OSCR) | 12/27/2023 - 1/22/2024 | 18.92% |
Viking Therapeutics (VKTX) | 12/27/2023 - 1/22/2024 | 18.28% |
Kemper (KMPR) | 12/27/2023 - 1/22/2024 | 17.71% |
Torm PLC Class A (TRMD) | 12/27/2023 - 1/22/2024 | 17.35% |
Glaukos (GKOS) | 12/27/2023 - 1/22/2024 | 16.76% |
Arcutis Biotherapeutics (ARQT) | 12/27/2023 - 1/22/2024 | 16.07% |
TMC the metals (TMC) | 12/27/2023 - 1/22/2024 | 14.91% |
Axsome Therapeutics (AXSM) | 12/27/2023 - 1/22/2024 | 14.32% |
Abercrombie & Fitch (ANF) | 12/27/2023 - 1/22/2024 | 14.02% |
HealthEquity (HQY) | 12/27/2023 - 1/22/2024 | 13.74% |
Cytokinetics (CYTK) | 12/27/2023 - 1/22/2024 | 13.63% |
Digitalbridge (DBRG) | 12/27/2023 - 1/22/2024 | 13.53% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
